IDEXX Laboratories Inc Total Liabilities
IDEXX Laboratories Inc total liabilities. Based on the latest financial reports, IDEXX Laboratories Inc (IDXX) has total liabilities worth $1.83 Billion USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check IDEXX Laboratories Inc (IDXX) asset resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of IDEXX Laboratories Inc (1991–2025)
Total liabilities of IDEXX Laboratories Inc from 1991 to 2025. This chart illustrates how IDEXX Laboratories Inc's total liabilities have evolved over time, based on quarterly financial data. Explore IDXX strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
IDEXX Laboratories Inc Competitors by Total Liabilities
The table below lists competitors of IDEXX Laboratories Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Live Nation Entertainment Inc
NYSE:LYV
|
USA | $26.36 Billion |
|
Ferrovial SE
NASDAQ:FER
|
USA | $19.82 Billion |
|
Block, Inc
NYSE:XYZ
|
USA | $18.31 Billion |
|
Telstra Group Ltd
AU:TLS
|
Australia | AU$28.90 Billion |
|
Sun Life Financial Inc.
TO:SLF
|
Canada | CA$372.96 Billion |
|
Goodman Group
AU:GMG
|
Australia | AU$8.65 Billion |
|
Itaú Unibanco Holding S.A
F:BVXB
|
Germany | €2.85 Trillion |
|
Ameriprise Financial Inc
NYSE:AMP
|
USA | $178.24 Billion |
Liability Composition Analysis (1991–2025)
This chart breaks down IDEXX Laboratories Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see IDEXX Laboratories Inc assets under control.
Liquidity & Leverage Metrics
IDEXX Laboratories Inc Total Liabilities Ratios Explained
IDEXX Laboratories Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.17 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.13 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.53 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how IDEXX Laboratories Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for IDEXX Laboratories Inc (1991–2025)
The table below shows the annual total liabilities of IDEXX Laboratories Inc from 1991 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $1.75 Billion | +2.78% |
| 2024-12-31 | $1.70 Billion | -4.35% |
| 2023-12-31 | $1.78 Billion | -16.96% |
| 2022-12-31 | $2.14 Billion | +22.37% |
| 2021-12-31 | $1.75 Billion | +5.14% |
| 2020-12-31 | $1.66 Billion | +0.43% |
| 2019-12-31 | $1.65 Billion | +6.99% |
| 2018-12-31 | $1.55 Billion | -12.49% |
| 2017-12-31 | $1.77 Billion | +7.83% |
| 2016-12-31 | $1.64 Billion | +5.13% |
| 2015-12-31 | $1.56 Billion | +23.08% |
| 2014-12-31 | $1.27 Billion | +77.82% |
| 2013-12-31 | $712.30 Million | +52.41% |
| 2012-12-31 | $467.35 Million | -4.86% |
| 2011-12-31 | $491.22 Million | +52.15% |
| 2010-12-31 | $322.86 Million | +9.84% |
| 2009-12-31 | $293.95 Million | -10.17% |
| 2008-12-31 | $327.24 Million | +24.02% |
| 2007-12-31 | $263.86 Million | +76.26% |
| 2006-12-31 | $149.70 Million | +23.35% |
| 2005-12-31 | $121.37 Million | +4.11% |
| 2004-12-31 | $116.58 Million | +7.36% |
| 2003-12-31 | $108.58 Million | +43.48% |
| 2002-12-31 | $75.68 Million | +6.03% |
| 2001-12-31 | $71.38 Million | -3.61% |
| 2000-12-31 | $74.05 Million | -2.44% |
| 1999-12-31 | $75.90 Million | -8.22% |
| 1998-12-31 | $82.70 Million | +11.31% |
| 1997-12-31 | $74.30 Million | +45.12% |
| 1996-12-31 | $51.20 Million | +53.29% |
| 1995-12-31 | $33.40 Million | +52.51% |
| 1994-12-31 | $21.90 Million | +52.08% |
| 1993-12-31 | $14.40 Million | +54.84% |
| 1992-12-31 | $9.30 Million | +40.91% |
| 1991-12-31 | $6.60 Million | -- |
About IDEXX Laboratories Inc
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urin… Read more